Insights

  • Date

  • Content Type

  • Reset

Case Study

Early phase modelling establishes opportunities and feasibility of ATMP for rare genetic disorder

3.02.23
A project consortium was launching an EU-funded clinical trial for a first-in-class advanced therapeutic medicinal
Read More

Case Study

Dendritic cell vaccine (oncology)

24.01.22
Small biotech US company developing a dendritic cell vaccine for the treatment of the Orphan
Read More

Case Study

Gene therapy (hematology)

24.01.22
Small pharmaceutical company with EMA approved gene therapy in need for support with HTA assessment
Read More

Case Study

Pre-IND Meeting

24.01.22
European client initiating US development of its gene therapy product.
Read More

Case Study

Autologous cell product (cartilage defect)

24.01.22
Client was a small biotech company developing an autologous cell product for cartilage defects in
Read More

Case Study

Development Plan for a combined tissue-engineered product (ATMP)

24.01.22
Small biotech company (SME) developing an allogenic tissue-engineered product (TEP) for the treatment of heart
Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more